UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000538
Receipt number R000000655
Scientific Title A randomized clinical trial for evaluating effects of activated donor liver mononuclear cells inoculation on liver transplantation recipients with hepatitis C (HCV).
Date of disclosure of the study information 2007/01/01
Last modified on 2018/06/12 21:29:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized clinical trial for evaluating effects of activated donor liver mononuclear cells inoculation on liver transplantation recipients with hepatitis C (HCV).

Acronym

A randomized clinical trial for evaluating effects of Liver mononuclear cells on HCV liver transplantation recipients.

Scientific Title

A randomized clinical trial for evaluating effects of activated donor liver mononuclear cells inoculation on liver transplantation recipients with hepatitis C (HCV).

Scientific Title:Acronym

A randomized clinical trial for evaluating effects of Liver mononuclear cells on HCV liver transplantation recipients.

Region

Japan


Condition

Condition

Liver transplantation recipients with HCV

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and toxicity of activated donor liver mononuclear cells inoculation to liver transplantation recipients with HCV.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

5-year survival rate, and SVR

Key secondary outcomes

Adverse events, Postoperative infectious complication rate, Median overall survival


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Participated patients will be randomly divided into two groups. One is cell therapy group and the other is untreated group. Patients in cell therapy group are injected activated donor liver mononuclear cells 3 days after liver transplantation.

Interventions/Control_2

Patients in untreated group are injected placebo without cells.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who are expected to be recipients for living-donor liver transplantation
Patients who have submitted a written informed consent
Patients with hepatitis C

Key exclusion criteria

Symptomatic infectious disease
Fluminant hepatitis
ABO incompatible transplantation
Retransplantation
Decision as ineligible by principal investigators

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideki Ohdan

Organization

Graduate school of biomedical sciences, Hiroshima university

Division name

Department of surgery, division of frontier medical science, programs for biomedical research

Zip code


Address

1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551

TEL

082-257-5222

Email

hohdan@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Masahiro Ohira

Organization

Graduate school of biomedical sciences, Hiroshima university

Division name

Department of surgery, division of frontier medical science, programs for biomedical research

Zip code


Address

1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551

TEL

082-257-5222

Homepage URL


Email

mohira@hiroshima-u.ac.jp


Sponsor or person

Institute

Department of surgery, division of frontier medical science, programs for biomedical research, Graduate school of biomedical sciences, Hiroshima university

Institute

Department

Personal name



Funding Source

Organization

Department of surgery, division of frontier medical science, programs for biomedical research, Graduate school of biomedical sciences, Hiroshima university

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2007 Year 04 Month 01 Day

Last follow-up date

2015 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2006 Year 12 Month 06 Day

Last modified on

2018 Year 06 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000655


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name